The Causes & Treatments for Autism | Dr. Karen Parker
In this episode, my guest is Dr. Karen Parker, Ph.D., professor of psychiatry and director of the Social Neurosciences Research Program at Stanford University School of Medicine.
December 11, 2023
2 hr 51 min
154
Full
183 of 417
Episode 154 · December 11, 2023
The Causes & Treatments for Autism | Dr. Karen Parker
0:00 / 2:51:19
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Andrew Huberman Episodes Around December 11, 2023
Episode 183 of 417 — walk the feed in the order it was published.
The Causes & Treatments for Autism | Dr. Karen Parker
Summary
In this episode, my guest is Dr. Karen Parker, Ph.D., professor of psychiatry and director of the Social Neurosciences Research Program at Stanford University School of Medicine. We discuss the biology of social connections and bonding in babies, children and adults. Dr. Parker explains our current understanding of autism and autism spectrum disorders: what they are, why the incidence of autism has increased so dramatically in recent years and both the current and emerging treatments for autism. We also discuss the condition formerly called “Asperger’s.” This episode ought to be highly relevant for anyone interested in child and human development, how social bonds form, and to those curious about autism and other spectrum conditions.
For show notes, including referenced articles and additional resources, please visit hubermanlab.com.
Use Ask Huberman Lab, our new AI-powered platform, for a summary, clips, and insights from this episode.
Thank you to our sponsors
AG1: https://drinkag1.com/huberman
LMNT: https://drinklmnt.com/hubermanlab
Waking Up: https://wakingup.com/huberman
Momentous: https://livemomentous.com/huberman
Timestamps
(00:00:00) Dr. Karen Parker
(00:01:30) Sponsors: LMNT & Waking Up
(00:06:25) Autism, Frequency, Diagnosis
(00:10:41) Early Interventions; Heritability & Autistic Traits
(00:13:00) Autistic Spectrums; Studying Autism
(00:21:29) Environment, Risk Factors & In Utero Development
(00:28:01) Sponsor: AG1
(00:31:26) Oxytocin, Vasopressin, Social Behavior & Parent-Child Bonding
(00:43:240 Oxytocin in Humans; Social Features of Autism, Intranasal Oxytocin
(00:55:16) Oxytocin & Autism; Benefit & Risks
(01:06:30) Neuroplasticity & Autism; Early Intervention; Challenges of Early Diagnosis
(01:14:30) MDMA & Autism
(01:17:05) Vasopressin, Social Interaction; Voles & Parenthood
(01:27:07) Human Social Connection, Oxytocin Levels & Autism
(01:33:45) Primate Model of Social Impairment
(01:42:47) Preclinical Animal Models, Mouse & Primates
(01:47:11) Primates, Biomarkers & Social Connection; Vasopressin
(01:52:20) Vasopressin Levels & Autism, Children & In Utero
(02:03:06) Cerebral Spinal Fluid (CSF) & Vasopressin; Urination; Alternative Therapies
(02:10:32) Intranasal Vasopressin, Children, Autism & Social Responsiveness
(02:19:15) Vasopressin & Social Connection, Mechanism & Future Studies
(02:26:35) Gut Microbiome & Vasopressin; Scientific Funding